273 related articles for article (PubMed ID: 37241232)
1. Chronic Periodontal Infection and Not Iatrogenic Interference Is the Trigger of Medication-Related Osteonecrosis of the Jaw: Insights from a Large Animal Study (PerioBRONJ Pig Model).
Troeltzsch M; Zeiter S; Arens D; Nehrbass D; Probst FA; Liokatis P; Ehrenfeld M; Otto S
Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241232
[No Abstract] [Full Text] [Related]
2. Further development of the MRONJ minipig large animal model.
Otto S; Pautke C; Martin Jurado O; Nehrbass D; Stoddart MJ; Ehrenfeld M; Zeiter S
J Craniomaxillofac Surg; 2017 Sep; 45(9):1503-1514. PubMed ID: 28803745
[TBL] [Abstract][Full Text] [Related]
3. A Drug Holiday Reduces the Frequency and Severity of Medication-Related Osteonecrosis of the Jaw in a Minipig Model.
Otto S; Pautke C; Arens D; Poxleitner P; Eberli U; Nehrbass D; Zeiter S; Stoddart MJ
J Bone Miner Res; 2020 Nov; 35(11):2179-2192. PubMed ID: 32568416
[TBL] [Abstract][Full Text] [Related]
4. Interventions for managing medication-related osteonecrosis of the jaw.
Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012432. PubMed ID: 28983908
[TBL] [Abstract][Full Text] [Related]
5. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
[TBL] [Abstract][Full Text] [Related]
6. Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ).
Otto S; Aljohani S; Fliefel R; Ecke S; Ristow O; Burian E; Troeltzsch M; Pautke C; Ehrenfeld M
Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34065104
[TBL] [Abstract][Full Text] [Related]
7. Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study.
Wazzan T; Kashtwari D; Almaden WF; Gong Y; Chen Y; Moreb J; Katz J
Spec Care Dentist; 2018 Nov; 38(6):356-361. PubMed ID: 30194738
[TBL] [Abstract][Full Text] [Related]
8. Low-level laser therapy prevents medication-related osteonecrosis of the jaw-like lesions via IL-1RA-mediated primary gingival wound healing.
Zheng Y; Dong X; Chen S; He Y; An J; Liu M; He L; Zhang Y
BMC Oral Health; 2023 Jan; 23(1):14. PubMed ID: 36627695
[TBL] [Abstract][Full Text] [Related]
9. Zoledronate induces osteonecrosis of the jaw in sheep.
Voss PJ; Stoddart M; Ziebart T; Zeiter S; Nelson K; Bittermann G; Schmelzeisen R; Poxleitner P
J Craniomaxillofac Surg; 2015 Sep; 43(7):1133-8. PubMed ID: 26154396
[TBL] [Abstract][Full Text] [Related]
10. Zoledronic acid increases the prevalence of medication-related osteonecrosis of the jaw in a dose dependent manner in rice rats (Oryzomys palustris) with localized periodontitis.
Messer JG; Mendieta Calle JL; Jiron JM; Castillo EJ; Van Poznak C; Bhattacharyya N; Kimmel DB; Aguirre JI
Bone; 2018 Mar; 108():79-88. PubMed ID: 29289789
[TBL] [Abstract][Full Text] [Related]
11. Preclinical models of medication-related osteonecrosis of the jaw (MRONJ).
Aguirre JI; Castillo EJ; Kimmel DB
Bone; 2021 Dec; 153():116184. PubMed ID: 34520898
[TBL] [Abstract][Full Text] [Related]
12. Periosteal microcirculatory reactions in a zoledronate-induced osteonecrosis model of the jaw in rats.
Janovszky Á; Szabó A; Varga R; Garab D; Boros M; Mester C; Beretka N; Zombori T; Wiesmann HP; Bernhardt R; Ocsovszki I; Balázs P; Piffkó J
Clin Oral Investig; 2015 Jul; 19(6):1279-88. PubMed ID: 25352470
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of medication-related osteonecrosis of the jaw: a comparative study of in vivo and in vitro trials.
Holtmann H; Lommen J; Kübler NR; Sproll C; Rana M; Karschuck P; Depprich R
J Int Med Res; 2018 Oct; 46(10):4277-4296. PubMed ID: 30091399
[TBL] [Abstract][Full Text] [Related]
14. Anti-angiogenic drug aggravates the degree of anti-resorptive drug-based medication-related osteonecrosis of the jaw by impairing the proliferation and migration function of gingival fibroblasts.
Zhao N; Li QX; Wang YF; Qiao Q; Huang HY; Guo CB; Guo YX
BMC Oral Health; 2023 May; 23(1):330. PubMed ID: 37245004
[TBL] [Abstract][Full Text] [Related]
15. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
16. Rodents as an animal model for studying tooth extraction-related medication-related osteonecrosis of the jaw: assessment of outcomes.
Hadad H; Matheus HR; Pai SI; Souza FA; Guastaldi FPS
Arch Oral Biol; 2024 Mar; 159():105875. PubMed ID: 38160519
[TBL] [Abstract][Full Text] [Related]
17. Zoledronate treatment duration is linked to bisphosphonate-related osteonecrosis of the jaw prevalence in rice rats with generalized periodontitis.
Messer JG; Jiron JM; Mendieta Calle JL; Castillo EJ; Israel R; Phillips EG; Yarrow JF; Van Poznak C; Kesavalu L; Kimmel DB; Aguirre JI
Oral Dis; 2019 May; 25(4):1116-1135. PubMed ID: 30712276
[TBL] [Abstract][Full Text] [Related]
18. Preventing or controlling periodontitis reduces the occurrence of osteonecrosis of the jaw (ONJ) in rice rats (Oryzomys palustris).
Castillo EJ; Messer JG; Abraham AM; Jiron JM; Alekseyenko AV; Israel R; Thomas S; Gonzalez-Perez GM; Croft S; Gohel A; Bhattacharyya I; Yarrow JF; Novince CM; Kimmel DB; Aguirre JI
Bone; 2021 Apr; 145():115866. PubMed ID: 33515777
[TBL] [Abstract][Full Text] [Related]
19. Removal of Pre-Existing Periodontal Inflammatory Condition before Tooth Extraction Ameliorates Medication-Related Osteonecrosis of the Jaw-Like Lesion in Mice.
Kim T; Kim S; Song M; Lee C; Yagita H; Williams DW; Sung EC; Hong C; Shin KH; Kang MK; Park NH; Kim RH
Am J Pathol; 2018 Oct; 188(10):2318-2327. PubMed ID: 30059656
[TBL] [Abstract][Full Text] [Related]
20. Medication-related osteonecrosis of the jaw after once-a-year intravenous zoledronic acid infusion for osteoporosis: Report of eight cases.
Favia G; Tempesta A; Limongelli L; Crincoli V; Maiorano E
Quintessence Int; 2016; 47(5):433-40. PubMed ID: 26665262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]